Document Detail

Effect of pretransplantation hemoglobin blood concentration on renal allograft survival and function.
MedLine Citation:
PMID:  20430165     Owner:  NLM     Status:  MEDLINE    
The effect of pretransplantation hemoglobin (Hb) concentration on the outcome of kidney transplantation (KTx) was studied in 188 adult kidney transplant recipients. Patients were divided into 2 groups: high Hb (>or=10 g/dL; n=97) and low Hb (<10 g/dL; n=91). Both groups were matched for recipient sex, donor age and sex, donor-recipient blood groups, indications for kidney transplantation, and degree of sensitization. Acute rejection episodes occurred in 20 patients in the high-Hb group (20.6%) and 18 in the low-Hb group (19.8%). Antithymocyte globulin-Fresenius therapy was required in 6 patients in the high-Hb group compared with 5 patients in the low-Hb group. Infection rate, 1-year actuarial patient and graft survival, incidence of delayed and slow graft function, and number of surgical complications were comparable between groups. Compared with the low Hb group, in the high-Hb group, hospital stay was longer, creatinine concentration at 12 months post-KTx and serum glucose concentration at 6 months post-KTx were significantly higher, and pre- and posttransplantation Hb concentrations were higher. The need for post-KTx transfusions was comparable between groups. Pretransplantation Hb concentration did not affect outcome except for longer initial hospital stay and 1-year creatinine concentration.
M M Abou-Jaoude; N Nawfal; R Najm; M Honeidi; J Shaheen; W Y Almawi
Related Documents :
15110615 - Evolving practice patterns in heart transplantation: a single-center experience over 15...
9392305 - Influence of donor and recipient ages and sex on graft function after pediatric renal t...
12846765 - Ten-year survival of second kidney transplants: impact of immunologic factors and renal...
15575905 - Kidney transplantation for systemic sclerosis improves survival and may modulate diseas...
3281045 - Acute renal failure due to focal necrotizing glomerulonephritis in a patient with non-h...
12641485 - Fluoroquinolones in the elderly: safety considerations.
Publication Detail:
Type:  Journal Article; Retracted Publication    
Journal Detail:
Title:  Transplantation proceedings     Volume:  42     ISSN:  1873-2623     ISO Abbreviation:  Transplant. Proc.     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-04-30     Completed Date:  2010-08-10     Revised Date:  2014-01-06    
Medline Journal Info:
Nlm Unique ID:  0243532     Medline TA:  Transplant Proc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  760-2     Citation Subset:  IM    
Copyright Information:
Copyright (c) 2010 Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antibodies, Monoclonal / therapeutic use
Antibodies, Monoclonal, Humanized
Antilymphocyte Serum / therapeutic use
Blood Glucose / analysis
Blood Group Antigens / metabolism
Creatinine / blood
Graft Rejection / epidemiology
Graft Survival
Hemoglobins / metabolism*
Immunoglobulin G / therapeutic use
Immunosuppressive Agents / therapeutic use
Kidney Transplantation / immunology,  physiology*
Postoperative Complications / epidemiology
Postoperative Period
Preoperative Period
Retrospective Studies
Treatment Outcome
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Antibodies, Monoclonal, Humanized; 0/Antilymphocyte Serum; 0/Blood Glucose; 0/Blood Group Antigens; 0/Hemoglobins; 0/Immunoglobulin G; 0/Immunosuppressive Agents; AYI8EX34EU/Creatinine; CUJ2MVI71Y/daclizumab
Retraction In:
Transplant Proc. 2013 Sep;45(7):2858   [PMID:  24159630 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The Hematopoietic Effect of Epotin (Recombinant Human Erythropoietin-alpha) on Maintenance Hemodialy...
Next Document:  The relationship between optimism and life satisfaction for patients waiting or not waiting for rena...